T cell subsets and sIL-2R/IL-2 levels in patients with glaucoma

Area of Science:

• Immunology
• Ophthalmology
• Cellular Biology

Background:

• Glaucomatous optic neuropathy is a leading cause of irreversible blindness.
• The role of cellular immunity in glaucoma pathogenesis is not fully understood.
• Investigating immune system markers may reveal new insights into glaucoma.

Purpose of the Study:

• To investigate the potential role of cellular immunity in glaucomatous optic neuropathy.
• To analyze T cell subsets and cytokine levels (IL-2, sIL-2R) in patients with normal pressure glaucoma (NPG) and primary open-angle glaucoma (POAG).
• To compare immune markers in glaucoma patients with age-matched healthy controls.

Main Methods:

• Peripheral blood samples were collected from 38 glaucoma patients (20 NPG, 18 POAG) and 19 controls.
• Enzyme-linked immunosorbent assay (ELISA) was used to measure soluble IL-2 receptor (sIL-2R) and IL-2 levels.
• Flow cytometry analyzed T cell subsets, and lymphocyte proliferation assays assessed T cell reactivity to phytohemagglutinin (PHA).

Main Results:

• Increased frequencies of CD8(+)HLA-DR(+) and CD3(+)CD8(+) lymphocytes were observed in NPG and POAG patients.
• Higher CD5(+) lymphocyte counts were found in POAG patients.
• Elevated sIL-2R concentrations were detected in both NPG and POAG groups, while IL-2 levels remained similar across groups. T cell reactivity to PHA was reduced in glaucoma patients.

Conclusions:

• Alterations in T cell subsets and sIL-2R levels suggest a role for the cellular immune system in glaucoma.
• These findings support the hypothesis that immune system dysregulation may contribute to the initiation or progression of glaucomatous optic neuropathy.
• Further research into immune mechanisms could lead to novel therapeutic strategies for glaucoma.